We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Immediate actions in response to detection of vaccine derived polio virus type 2 (VDPV2) in London sewage samples.
Information on phosphine, for responding to chemical incidents.
List of those receiving pre-release access to UK Health Security Agency critical care annual statistical releases.
Lists of those receiving pre-release access to UK Health Security Agency National flu and COVID-19 surveillance reports.
List of those receiving pre-release access to the annual UK Health Security Agency mandatory healthcare associated infections (HCAI) statistical release.
Guidance about infectious measles linked to international travel, including air, sea and land crossings
Information on the smallpox vaccination used to protect those who have had contact with an mpox case against the virus MPXV.
National Chlamydia Screening Programme (NCSP) leaflet for local printing.
Information and infographics with advice for people travelling to the Middle East from the UK, including translated versions.
Epidemiological protocols to assess early Middle East respiratory syndrome coronavirus (MERS-CoV) cases and their close contacts in the UK.
The benefits of using the combined measles, mumps, rubella (MMR) vaccine instead of single vaccines for the 3 diseases.
Information on tetrachloroethylene (also known as tetrachloroethene), for use in responding to chemical incidents.
Template letter to clinicians caring for patients who are immunosuppressed or are about to be immunosuppressed.
Statistical work programme outlining areas for development and focus in UK Health Security Agency’s statistical publications.
The risk to UK residents travelling to the affected areas is very low.
Details for the influenza vaccine uptake data collection (GP patient survey) from GP practices for the 2022 to 2023 flu season.
The SAMBA II SARS-CoV-2/RSV test is for the qualitative detection of nucleic acids from SARS-CoV-2 and/or Respiratory Syncytial Virus in human respiratory specimens.
Documentation to assist the public health response in the management of accommodation sites associated with one or more cases of Legionnaires’ disease.
National surveillance of targeted 4CMenB vaccination to protect individuals at higher risk of gonorrhoea infection in England.
Guidance to support the detection, investigation, and control of STI outbreaks and the development of local STI outbreak control strategies.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).